Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Grifols Therapeutics LLC
Sponsor

Grifols Therapeutics LLC

United States 8368 Clayton Boulevard, 27520-9464, United States

About the sponsor

Research activity in Alpha-1 antitrypsin deficiency centers on alpha1-proteinase inhibitor replacement, including subcutaneous and intravenous administration in people with AATD.

  • Alpha1-Proteinase Inhibitor replacement
  • Subcutaneous and intravenous delivery
  • Pharmacokinetics and systemic exposure
  • Long-term safety in AATD

The sponsor also studies treatment effects in pulmonary emphysema linked to alpha-1-antitrypsin deficiency, with attention to preserving lung structure and limiting disease progression.

About Specializations

Grifols Therapeutics LLC runs clinical trials in conditions such as Chronic lymphocytic leukaemia, Non-Hodgkin's lymphoma, Plasma cell myeloma, Emphysema, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Grifols Therapeutics LLC

Alpha-1 antitrypsin deficiency

Recruiting
InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Human Alpha1-Proteinase Inhibitor
  • Sponsor:Grifols Therapeutics LLC

Chronic lymphocytic leukaemia+2

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Grifols Therapeutics LLC

Chronic lymphocytic leukaemia+2

Not yet recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Grifols Therapeutics LLC

Emphysema

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alpha-1-Proteinase Inhibitor (Human)
  • Sponsor:Grifols Therapeutics LLC

Emphysema

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alpha-1-Proteinase Inhibitor (Human)
  • Sponsor:Grifols Therapeutics LLC

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.